148 related articles for article (PubMed ID: 2848156)
21. The glucagonoma syndrome in a Chinese man.
Lee KO; Chan HL; Lee HL
Ann Acad Med Singap; 1985 Apr; 14(2):312-6. PubMed ID: 2994543
[TBL] [Abstract][Full Text] [Related]
22. Glucagonoma syndrome and necrolytic migratory erythema.
Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
[TBL] [Abstract][Full Text] [Related]
23. Glucagonoma syndrome associated with necrolytic migratory erythema.
Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
[TBL] [Abstract][Full Text] [Related]
24. The glucagonoma syndrome--report of a case without overt diabetes.
Leibovici V; Granot E; Eid A; Goldin E; Okon E
J Dermatol; 1987 Oct; 14(5):491-6. PubMed ID: 2830323
[No Abstract] [Full Text] [Related]
25. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
26. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Mullans EA; Cohen PR
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
[TBL] [Abstract][Full Text] [Related]
27. [Glucagonoma syndrome. Unusual histologic image].
Poiares Baptista A; Tellechea O; Aguiar M; Leitão A
Ann Dermatol Venereol; 1987; 114(1):55-8. PubMed ID: 3034125
[No Abstract] [Full Text] [Related]
28. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
29. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
Kasper CS
Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic glucagonoma and deep vein thrombosis].
Guilarte López-Mañas J; Bellot García V; Fernández Pérez R; Caballero Plasencia A
Gastroenterol Hepatol; 1998 Dec; 21(10):483-5. PubMed ID: 9927793
[TBL] [Abstract][Full Text] [Related]
31. [Necrolytic migratory erythema associated with glucagonoma].
Mendoza-Guil F; Hernández-Jurado I; Burkhardt P; Linares J; Naranjo R
Actas Dermosifiliogr; 2005 Apr; 96(3):175-8. PubMed ID: 16476361
[TBL] [Abstract][Full Text] [Related]
32. Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis?
Kasper CS; McMurry K
J Am Acad Dermatol; 1991 Sep; 25(3):534-41. PubMed ID: 1655838
[TBL] [Abstract][Full Text] [Related]
33. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
Johnson SM; Smoller BR; Lamps LW; Horn TD
J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
[TBL] [Abstract][Full Text] [Related]
34. Necrolytic migratory erythema associated with an islet cell tumour of the pancreas.
Verbov J
Dermatologica; 1981; 163(2):189-94. PubMed ID: 6269919
[TBL] [Abstract][Full Text] [Related]
35. [A case of glucagonoma presenting with epigastric and back pain as an initial manifestation].
Hazaki R; Tanaka K; Yamamoto H; Matsumoto H; Shimada T; Inoue Y; Misaki F; Kadowaki S; Fujita T; Iwasaki T
Nihon Naika Gakkai Zasshi; 1987 Apr; 76(4):592-3. PubMed ID: 3039028
[No Abstract] [Full Text] [Related]
36. The glucagonoma syndrome (necrolytic migratory erythema) and zinc.
Amon RB; Swenson KH; Hanifin JM; Hambidge KM
N Engl J Med; 1976 Oct; 295(17):962. PubMed ID: 184387
[No Abstract] [Full Text] [Related]
37. [Glucagonoma disclosed by pancreatic calcifications].
Vaillant G; Verges B; Mabille JP; Piard F; Caillet ML; Putelat R
Presse Med; 1987 Sep; 16(31):1544. PubMed ID: 2821532
[No Abstract] [Full Text] [Related]
38. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
[TBL] [Abstract][Full Text] [Related]
39. A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compression.
Staren ED; Steinecker GA; Gould VE
J Surg Oncol; 1987 Aug; 35(4):249-52. PubMed ID: 3039255
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
Ditty JF; Lang PG
South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
